GlassScriptPhysician profile
Lucas A Cook
NPI 1639582901
$2,358.00
in general payments reported to CMS, 2019-2025
17 companies · $162 in 2025
The $162 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,257 · 2020: $51.01 · 2021: $136 · 2022: $364 · 2023: $299 · 2024: $89.22 · 2025: $162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $550.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $549.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,272.98 | 2019-2025 | Precision7, Total30 |
| Abbvie INC. | $372.41 | 2022-2023 | Durysta, Xen Glaucoma Treatment System, Lumigan |
| Regeneron Healthcare Solutions, INC. | $85.38 | 2019-2024 | Eylea Hd, Eylea |
| Bausch & Lomb Americas INC. | $84.79 | 2024-2025 | Miebo, Xiidra, Infuse |
| Allergan, INC. | $75.61 | 2020-2022 | |
| Johnson & Johnson Vision Care, INC. | $70.13 | 2019-2025 | Acuvue |
| Oyster Point Pharma, INC. | $69.82 | 2022-2024 | Tyrvaya |
| Shire North American Group INC | $63.62 | 2019 | |
| Novartis Pharmaceuticals Corporation | $48.17 | 2020-2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $41.36 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $37.79 | 2021 | |
| Horizon Therapeutics Plc | $34.78 | 2022 | |
| Genentech USA, INC. | $34.54 | 2025 | Vabysmo |
| Tarsus Pharmaceuticals, INC. | $22.87 | 2024 | Xdemvy |
| Aerie Pharmaceuticals, INC. | $15.38 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lkc Technologies, INC. | $14.55 | 2025 | |
| Harrow Eye, LLC | $13.82 | 2024 | Iheezo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lucas Cook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.